After Pharmacy Deals, New Opioid Sellers In Legal ‘Bull’s-Eye’

November 2, 2022

Multibillion-dollars settlements with top pharmacy retailers will shift a historic barrage of opioid litigation away from the last of its early targets and toward groups of pharmaceutical sellers and advisers whose business practices and legal defenses have received little attention, according to the plaintiff's counsel and court records.

The preliminary deals covering CVS Pharmacy and Walgreens - as well as Walmart, according to a source - became public on Wednesday, nearly five years after the formation of a multidistrict litigation for thousands of opioid-crisis lawsuits on behalf of local governments and Native American tribes.

Find the original article here.

Download

Our Locations

Please Contact Us for an In-Person Appointment